| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership | 
|---|---|---|---|---|---|---|---|
| Theseus Pharmaceuticals, Inc. | President and CEO, Director | Common Stock | 351K | $1.07M | $3.05 | Nov 11, 2022 | Direct | 
| Theseus Pharmaceuticals, Inc. | President and CEO, Director | Restricted Stock Units | 45.6K | $139K | $3.05 | Mar 1, 2023 | Direct | 
| Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 70.9K | $58.8K | $0.83 | Oct 21, 2021 | The Timothy P. Clackson Irrevocable GST Trust of 2020 | 
| Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 20.1K | $16.7K | $0.83 | Oct 21, 2021 | Direct | 
| Elevation Oncology, Inc. | Director | Common Stock | 0 | $0 | $0.36 | Jul 23, 2025 | The Timothy P. Clackson Irrevocable GST Trust of 2020 | 
| Theseus Pharmaceuticals, Inc. | President and CEO, Director | Stock Option (right to buy) | 274K | Feb 17, 2023 | Direct | ||
| Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 0 | Jul 23, 2025 | Direct | ||
| Forma Therapeutics Holdings, Inc. | Director | Common Stock | 0 | $5.05 | Oct 14, 2022 | Direct | |
| Forma Therapeutics Holdings, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 14, 2022 | Direct | 
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role | 
|---|---|---|---|---|---|---|---|
| ELEV | Elevation Oncology, Inc. | Jul 23, 2025 | 5 | -$17K | 4 | Jul 24, 2025 | Director | 
| ELEV | Elevation Oncology, Inc. | Jun 5, 2025 | 1 | $0 | 4 | Jun 9, 2025 | Director | 
| ELEV | Elevation Oncology, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director | 
| ELEV | Elevation Oncology, Inc. | Sep 1, 2023 | 1 | $0 | 4 | Sep 5, 2023 | Director | 
| ELEV | Elevation Oncology, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director | 
| THRX | Theseus Pharmaceuticals, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 2, 2023 | President and CEO, Director | 
| THRX | Theseus Pharmaceuticals, Inc. | Feb 17, 2023 | 1 | $0 | 4 | Feb 21, 2023 | President and CEO, Director | 
| THRX | Theseus Pharmaceuticals, Inc. | Nov 11, 2022 | 1 | $17K | 4 | Nov 14, 2022 | President and CEO, Director | 
| FMTX | Forma Therapeutics Holdings, Inc. | Oct 14, 2022 | 8 | $0 | 4 | Oct 14, 2022 | Director | 
| ELEV | Elevation Oncology, Inc. | Jun 17, 2022 | 2 | $0 | 4 | Jun 22, 2022 | Director | 
| FMTX | Forma Therapeutics Holdings, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director | 
| THRX | Theseus Pharmaceuticals, Inc. | Feb 18, 2022 | 1 | $0 | 4 | Feb 23, 2022 | President and CEO, Director | 
| THRX | Theseus Pharmaceuticals, Inc. | Dec 21, 2021 | 1 | $25.4K | 4 | Dec 22, 2021 | President and CEO, Director | 
| XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | 10%+ Owner | 
| THRX | Theseus Pharmaceuticals, Inc. | Oct 6, 2021 | 0 | $0 | 3 | Oct 6, 2021 | President and CEO, Director | 
| ELEV | Elevation Oncology, Inc. | Jun 24, 2021 | 0 | $0 | 3 | Jun 24, 2021 | Director | 
| FMTX | Forma Therapeutics Holdings, Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |